Reevaluation of host ranges of feline leukemia virus subgroups

Microbes and Infection

Volumn 5, Issue 11, 2003, Pages 947-950

  Nakata, Risa ^a,b   Miyazawa, Takayuki ^a,c   Shin, Yeon Sil ^c   Watanabe, Rie ^a   Mikami, Takeshi ^b   Matsuura, Yoshiharu ^a  

^a OSAKA UNIVERSITY   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Feline leukemia virus; Host range; Infection; Pseudotype assay; Receptor

Indexed keywords

ARTICLE; CELL LINE; CONTROLLED STUDY; EVALUATION; FELINE LEUKEMIA VIRUS; HOST RANGE; HUMAN; HUMAN CELL; MAMMAL CELL; MURINE LEUKEMIA VIRUS; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS TRANSMISSION;

FELIDAE; FELINE LEUKEMIA VIRUS; MAMMALIA; MURINAE; MURINE LEUKEMIA VIRUS; MUSTELA; MUSTELA VISON; ORYCTOLAGUS CUNICULUS;

EID: 0042572275     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(03)00180-1     Document Type: Article

References (24)

1. Jarrett O., Laird H.M., Hay D. Determinants of the host range of feline leukemia viruses. J. Gen. Virol. 20:1973;169-175.
2. Sarma P.S., Log T. Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests. Virology. 54:1973;160-169.
3. Stewart M.A., Warnock M., Wheeler A., Wilkie N., Mullins J.I., Onions D.E., Neil J.C. Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses. J. Virol. 58:1986;825-834.
4. Overbaugh J., Riedel N., Hoover E.A., Mullins J.I. Transduction of endogenous envelope genes by feline leukaemia virus in vitro. Nature. 332:1988;731-734.
5. Riedel N., Hoover E.A., Dornsife R.E., Mullins J.I. Pathogenic and host range determinants of the feline aplastic anemia retrovirus. Proc. Natl. Acad. Sci. USA. 85:1988;2758-2762.
6. Rigby M.A., Rojko J.L., Stewart M.A., Kociba G.J., Cheney C.M., Rezanka L.J., Mathes L.E., Hartke J.R., Jarrett O., Neil J.C. Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukemia viruses with chimeric envelope genes. J. Gen. Virol. 73:1992;2839-2847.
7. Towers G., Bock M., Martin S., Takeuchi Y., Stoye J.P., Danos O. A conserved mechanism of retrovirus restriction in mammals. Proc. Natl. Acad. Sci. USA. 97:2000;12295-12299.
8. Riedel N., Hoover E.A., Gasper P.W., Nicolson M.O., Mullins J.I. Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma. J. Virol. 60:1986;242-250.
9. Donahue P.R., Hoover E.A., Beltz G.A., Riedel N., Hirsch V.M., Overbaugh J., Mullins J.I. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J. Virol. 62:1988;722-731.
10. Cosset F.L., Morling F.J., Takeuchi Y., Weiss R.A., Collins M.K., Russell S.J. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J. Virol. 69:1995;6314-6322.
11. Cosset F.L., Takeuchi Y., Battini J.L., Weiss R.A., Collins M.K. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69:1995;7430-7436.
12. Takeuchi Y., Cosset F.L., Lachmann P.J., Okada H., Weiss R.A., Collins M.K. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J. Virol. 68:1994;8001-8007.
13. Jarrett O., Ganière J.P. Comparative studies of the efficacy of a recombinant feline leukemia virus vaccine. Vet. Rec. 138:1996;7-11.
14. Ramsey I.K., Spibey N., Jarrett O. The receptor binding site of feline leukemia virus surface glycoprotein is distinct from the site involved in virus neutralization. J. Virol. 72:1998;3268-3277.
15. Ikeda Y., Tomonaga K., Kawaguchi Y., Kohmoto M., Inoshima Y., Tohya Y., Miyazawa T., Kai C., Mikami T. Feline immunodeficiency virus can infect a human cell line (MOLT-4 cells) but establishes a state of latency in the cells. J. Gen. Virol. 77:1996;1623-1630.
16. Moser M., Burns C.C., Boomer S., Overbaugh J. The host range and interference properties of two closely related feline leukemia virus variants suggest that they use distinct receptors. Virology. 242:1998;366-377.
17. Ghosh A.K., Bachmann M.H., Hoover E.A., Mullins J.I. Identification of a putative receptor for subgroup A feline leukemia virus on feline T cells. J. Virol. 66:1992;3707-3714.
18. Miyazawa T. Infections of feline leukemia virus and feline immunodeficiency virus. Front. Biosci. 7:2002;d504-d518.
19. Jarrett O., Hardy W.D. Jr., Golder M.C., Hay D. The frequency of occurrence of feline leukaemia virus subgroups in cats. Int. J. Cancer. 21:1978;334-337.
20. Hardy W.D. Jr, Hess P.W., MacEwan E.G., McClelland A.J., Zuckerman E.E., Essex M., Cotter S.M., Jarrett O. Biology of feline leukemia virus in the natural environment. Cancer Res. 36:1976;582-588.
21. Galili U. The α-gal epitope (Galα1-3Galβ1-4GlcNAc-R) in xenotransplantation. Biochimie. 83:2001;557-563.
22. Takeuchi Y., Porter C.D., Strahan K.M., Preece A.F., Gustafsson K., Cosset F.L., Weiss R.A., Collins M.K. Sensitization of cells and retroviruses to human serum by (α1-3)galactosyltransferase. Nature. 379:1996;85-88.
23. Takeuchi Y., Liong S.H., Bieniasz P.D., Jager U., Porter C.D., Friedman T., McClure M.O., Weiss R.A. Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(α1-3)galactosylation. J. Virol. 71:1997;6174-6178.
24. Kurihara T., Miyazawa T., Miyagawa S., Tomonaga K., Hazama K., Yamada J., Shirakura R., Matsuura Y. Sensitivity to human serum of gammaretroviruses produced from pig endothelial cells transduced with glycosyltransferase gene. Xenotransplantation. 2003;. (in press).